China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recognizing the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva has opened its expanded Shanghai facility. The facility is 11 000 m2, fully operational, and designed to help advance and accelerate the development of novel therapeutics. Customers have access to a wide range of technologies, solutions, and services, including Cytiva’s Fast Trak training center, a Center of Excellence for single-use technologies, and a new automation and digital lab. It is also home to China’s online experience center, customized bioprocess solutions labs and compliance validation labs.

For those international medical device companies aiming to localize in China, what exactly does "manufactured within China" mean? To what extent does "localization" qualify as "manufactured within China"?

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

MGI Tech said last week that its DNBSeq-G99 sequencer has been approved as a medical device by China's National Medical Products Administration (NMPA).

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

It is stated that from 30 August 2023, all travelers entering China will no longer need to undergo any COVID-19 testing.

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

On August 13th, China's State Council issued a 24-point guideline covering six areas.